Cite
HARVARD Citation
Ostenfeld, T. et al. (2013). Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double‐blind, placebo‐controlled study. European journal of pain. pp. 844-857. [Online].